Detrusor Activity Recovery in Acute Traumatic Spinal Cord Injuries

Sponsor
Pusan National University Yangsan Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05207826
Collaborator
Coloplast A/S (Industry)
30
22

Study Details

Study Description

Brief Summary

Determining the most appropriate time to evaluate detrusor activity in urodynamic studies for both traumatic and non-traumatic spinal cord injuries

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Cystometrogram

Detailed Description

The detrusor activity in the acute phase of the spinal cord injury changes with the development of the spinal shock. Spinal shock is a phase of areflexic phase after the spinal cord injury that is primarily influenced by the severity of the injury and the neurological level of injury. Detrusor activity shows areflexic in the spinal shock phase, followed by a return of detrusor activity at the end of the spinal shock.

There was no recent study to provide evidence of an appropriate time to assess detrusor muscle activity through urodynamic studies. There were only a few limited studies on detrusor activity following spinal cord injury from 1960 to 1970. However, when the urodynamic study should be performed is still controversial.

Knowing the patterns of detrusor activity following spinal cord injuries is critical to determining the appropriate timing for intermittent catheterization, which is the standard emptying method of choice. If clinicians fail to understand true detrusor activity as early as possible, the patient will suffer from unnecessary indwelling catheter voiding, resulting in impaired quality of life in the acute phase.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
30 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Determining the Most Appropriate Time to Evaluate Detrusor Activity Recovery in Acute Traumatic Spinal Cord Injuries
Anticipated Study Start Date :
Mar 1, 2022
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Outcome Measures

Primary Outcome Measures

  1. Detrusor activity recovery [Every 3 days in spinal shock phase (up to 3 months)]

    Pressure change (Detrusor pressure change in filling cystometrogram)

Secondary Outcome Measures

  1. Reflexes [Every 3 days in spinal shock phase (up to 3 months)]

    Superficial reflex and pathologic reflex (Cremasteric reflex, Dartos reflex, BC reflex, anal reflex, Babinski reflex, delayed plantar reflex)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Acute onset suprasacral spinal cord injury with both traumatic and non-traumatic causes within the first 15 days after spinal cord injury(very acute phase of SCI according to European Multicenter Study about SCI : the first 15 d (very acute), between 16-40 d (acute I), and 3 mo (acute II), 6 mo (acute III), and 12 mo (chronic) after SCI)

  • Age older than 18

  • Inpatient

  • Patients with spinal cord injuries who initially keep the indwelling catheter

  • Patients with or without spinal shock

Exclusion Criteria:

nstable vital sign (using Inotropics or vasopressors or antiarrhythmic agents)

  • Current urinary tract infection

  • Agitated behavior (Richmond Agitation and Sedation Scale of +2 to +4)

  • Decreased mentality (RASS of -2 to -5)

  • Concomitant sacral lesions (Ex. Sacral fracture, pelvic bone fracture, urologic trauma)

  • Concomitant supraspinal lesions (Ex. Traumatic brain injury, old stroke, Parkinson disease)

  • Uncontrolled DM

  • Medical history of lower urinary tract dysfunction (Ex. BPH, Malignancy)

  • Uncontrlled autonomic dysreflexia (In case of autonomic dysreflexia, defined according to ISAFSCI (International Standards to document remaining Autonomic Function after SCI) as an increase in systolic blood pressure 20 mm Hg or greater from baseline

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Pusan National University Yangsan Hospital
  • Coloplast A/S

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sungchul Huh, Assistant professor, Pusan National University Yangsan Hospital
ClinicalTrials.gov Identifier:
NCT05207826
Other Study ID Numbers:
  • DRASS
First Posted:
Jan 26, 2022
Last Update Posted:
Jan 26, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 26, 2022